Scots launch orphan fund to pay for drugs that HTA bodies reject
This article was originally published in Scrip
Executive Summary
The Scottish government has launched a £21 million, one-year fund to pay for orphan medicines that have not been recommended for NHS use by the country's HTA body, the Scottish Medicines Consortium.